Charles River Laboratories International Inc
CRL
Detailliertes Diagramm anzeigen
180.100USD
+0.990+0.55%
Handelsschluss 10/31, 16:00（ET）Kurse um 15 Minuten verzögert
8.86BMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
+0.55%
5 Tage
-5.69%
1 Monat
+15.11%
6 Monate
+51.83%
Seit Jahresbeginn
-2.44%
1 Jahr
-0.71%
Detailliertes Diagramm anzeigen
TradingKey Aktienbewertung von Charles River Laboratories International Inc
Währung: USD Aktualisiert: 2025-10-30Wichtige Einblicke
Die Fundamentaldaten des Unternehmens sind relativ stabil. Seine Bewertung wird als angemessen bewertet angesehen,und die institutionelle Anerkennung ist sehr hoch. In den letzten 30 Tagen haben mehrere Analysten die Aktie mit einer Halten bewertet. Trotz einer durchschnittlichen Aktienmarktperformance zeigt das Unternehmen starke Fundamentaldaten und technische Indikatoren. Der Aktienkurs bewegt sich seitwärts zwischen den Unterstützungs- und Widerstandsniveaus, was ihn für schwankungsorientiertes Trading geeignet macht.
Charles River Laboratories International Inc Bewertung
Widerstand & Unterstützung
Keine Daten
Radar Chart
Aktueller Preis
Vorher
Analysten-Ziel
Basierend auf insgesamt
19
Analysten
Halten
Aktuelles Rating
188.959
Kursziel
+4.89%
Aufwärtspotenzial
Hinweis: Analystenbewertungen und Kursziele werden von LSEG ausschließlich zu Informationszwecken bereitgestellt und stellen keine Anlageberatung dar.
Charles River Laboratories International Inc Highlights
HöhepunkteRisiko
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
valuation_underestimated
valuation_underestimated_desc%!(EXTRA string=PE, string=-138.20)
institutional_decreasing_position
institutional_decreasing_position_desc%!(EXTRA string=51.65M, string=17.34%)
institutional_hold%!(EXTRA string=John Rogers)
institutional_hold_desc%!(EXTRA string=John Rogers, string=1.42M)
Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Keine Daten
Gesamteinnahmen
Keine Daten
Charles River Laboratories International Inc Informationen
Charles River Laboratories International, Inc. provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. The Company's Research Models and Services segment is comprised of three businesses that provide foundational tools that enables its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.
BörsenkürzelCRL
UnternehmenCharles River Laboratories International Inc
CEOMr James C. Foster
Websitehttps://www.criver.com/
Verwandte Finanzinstrumente
-0.23%
-2.31%
+6.22%
0.00%
+0.73%
-0.73%
+0.78%
+4.15%
+1.50%
+3.92%
-1.06%
+2.33%
+0.13%
-0.14%
-0.72%
+1.14%
+2.56%
-2.17%
+1.74%
+1.83%Beliebte Symbole
